You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MPS

Showing 1 - 25 of 668
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Transplant Rejection Trial (Enteric-Coated Mycophenolate Sodium (EC-MPS))

Not yet recruiting
  • Kidney Transplant Rejection
  • Enteric-Coated Mycophenolate Sodium (EC-MPS)
  • (no location specified)
May 23, 2023

MPS IVA, MPS VI Trial in Oakland (Vosoritide Injection [Voxzogo])

Not yet recruiting
  • MPS IVA
  • MPS VI
  • Vosoritide Injection [Voxzogo]
  • Oakland, California
    UCSF Benioff Children's Hospital Oakland
May 4, 2023

MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))

Withdrawn
  • MPS I
  • +2 more
  • SIG-005 (hIDUA Producing Spheres)
  • Porto Alegre, Brazil
  • +2 more
Dec 16, 2022

Patients With Sanfilippo Disease(s) (MPS3)

Not yet recruiting
  • Sanfilippo Syndrome
  • MPS3
    • Fairfax, Virginia
      LDRTC
    Jan 20, 2023

    MPS I Trial in Oakland (SB-318)

    Terminated
    Has Results
    • MPS I
    • SB-318
    • Oakland, California
      UCSF Benioff Children's Hospital Oakland
    Jan 6, 2023

    MPS II Immunophenotyping

    Recruiting
    • MPS II
    • +2 more
      • Durham, North Carolina
        Duke University
      Jun 3, 2022

      MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)

      Not yet recruiting
      • MPS-IH (Hurler Syndrome)
      • Experimental: OTL-203
      • Active Comparator: Allo-HSCT
      • Oakland, California
      • +6 more
      Nov 27, 2023

      Examinations for Asymptomatic MPS I Infants in Taiwan

      Recruiting
      • MPS I
      • MPS I
      • Taipei, Taiwan
        Mackay Memorial Hospital
      Mar 2, 2022

      Mucopolysaccharidosis II Trial in Cincinnati (DNL310)

      Enrolling by invitation
      • Mucopolysaccharidosis II
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Oct 10, 2023

      Mucopolysaccharidosis Type II (MPS II) Trial in Oakland, Montréal (RGX-121)

      Recruiting
      • Mucopolysaccharidosis Type II (MPS II)
      • RGX-121
      • Oakland, California
      • +1 more
      Oct 6, 2022

      Mucopolysaccharidosis Type II (MPS II) Trial in Brazil, United States (RGX-121)

      Recruiting
      • Mucopolysaccharidosis Type II (MPS II)
      • RGX-121
      • Oakland, California
      • +4 more
      Dec 22, 2022

      MPS IIIA, Sanfilippo Syndrome, Sanfilippo A Trial in Pittsburgh, North Adelaide, Santiago De Compostela (ABO-102)

      Terminated
      • MPS IIIA
      • +3 more
      • Pittsburgh, Pennsylvania
      • +2 more
      Jan 11, 2023

      Mucopolysaccharidosis (MPS), Hunter Syndrome Trial (ELAPRASE, Rituximab, Methotrexate)

      Not yet recruiting
      • Mucopolysaccharidosis (MPS)
      • Hunter Syndrome
      • (no location specified)
      Aug 8, 2022

      Mucopolysaccharidosis Type I (MPS I), Hurler Syndrome, Hurler-Scheie Syndrome Trial in Orange, Philadelphia, Porto Alegre

      Active, not recruiting
      • Mucopolysaccharidosis Type I (MPS I)
      • +2 more
      • RGX-111
      • Orange, California
      • +3 more
      Jan 9, 2023

      MPS III B Trial in Worldwide (AX 250)

      Not yet recruiting
      • MPS III B
      • AX 250
      • Oakland, California
      • +4 more
      Aug 8, 2022

      Mucopolysaccharidosis II, MPS II Trial in United States (SB-913)

      Terminated
      Has Results
      • Mucopolysaccharidosis II
      • MPS II
      • SB-913
      • Oakland, California
      • +4 more
      Oct 21, 2022

      Prostate Cancer Trial in Phoenix (MyProstateScore)

      Enrolling by invitation
      • Prostate Cancer
      • MyProstateScore
      • Phoenix, Arizona
        Arizona State Urological Institute
      Jan 17, 2023

      Study of Patients With MPS IIIA Treated With ABO-102

      Enrolling by invitation
      • Mucopolysaccharidosis III-A
      • ABO-102
      • Columbus, Ohio
      • +2 more
      Nov 8, 2022

      MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))

      Recruiting
      • MPS I
      • +8 more
      • Aldurazyme (laronidase)
      • San Francisco, California
        University of California
      Apr 21, 2022

      MPS (RaDiCo Cohort) (RaDiCo-MPS)

      Recruiting
      • Mucopolysaccharidosis I
      • +7 more
        • Angers, France
        • +22 more
        Sep 12, 2023

        Mucopolysaccharidosis Type IIIB, MPS III B Trial in Worldwide (AX 250)

        Active, not recruiting
        • Mucopolysaccharidosis Type IIIB
        • MPS III B
        • AX 250
        • Oakland, California
        • +7 more
        Jan 16, 2023

        Mucopolysaccharidosis I Trial in Wuhan (Laronidase)

        Recruiting
        • Mucopolysaccharidosis I
        • Wuhan, China
          Investigational Site Number :1560001
        Jan 15, 2023

        Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome), Mucopolysaccharidosis Type IH, MPS IH, Hurler Syndrome Trial

        Withdrawn
        • Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome)
        • +2 more
        • Autologous Plasmablasts
        • (no location specified)
        Oct 5, 2022

        Sanfilippo Syndrome Type A (MPS IIIA) Trial in Oakland, Chapel Hill, Ankara (SOBI003)

        Completed
        Has Results
        • Sanfilippo Syndrome Type A (MPS IIIA)
        • Oakland, California
        • +2 more
        Feb 2, 2022

        Myofascial Pain Syndrome, Trigger Point Pain, Myofascial Trial (conventional therapy, Experimental group 1 : pressure release

        Not yet recruiting
        • Myofascial Pain Syndrome
        • Trigger Point Pain, Myofascial
        • conventional therapy
        • +2 more
        • (no location specified)
        Jan 9, 2023